Faculty
Oncology Division
Alphabetical list (active faculty):   
Mark A. Fiala

Mark A. Fiala, MSW

Instructor

Department of Medicine

Oncology Division

Bone Marrow Transplantation & Leukemia

Research Interests

  • Cancer health disparities
  • Healthcare decision making and patient preferences
  • Healthcare utilization and economics
  • Epidemiology of multiple myeloma and related disorders

Contact

  • 314-273-2783 (office)
  • 314-273-0580 (fax)
  • Division of Oncology
    Mail Stop 8056-0029-11
    Washington University
    660 South Euclid Avenue
    St. Louis, MO 63110
  • Room 11303, Mid-Campus Center (office)

Peer-reviewed Manuscripts

  • A Single Center Retrospective Study of Daratumumab, Pomalidomide, and Dexamethasone as 2nd-Line Therapy in Multiple Myeloma
    Liu L, Fiala M, Gao F, King J, Goldsmith S, Wildes TM, Stockerl-Goldstein K, Vij R, Schroeder MA
    Leuk Lymphoma 2021 Dec;62(12):3043-3046
  • Disparities in Health Care Affordability Among Childhood Cancer Survivors Persist Following the Affordable Care Act
    Fiala MA
    Pediatr Blood Cancer 2021 Dec;68(12):e29370
  • A Pilot Study of 3D Tissue-Engineered Bone Marrow Culture as a Tool to Predict Patient Response to Therapy in Multiple Myeloma
    Alhallak K, Jeske A, de la Puente P, Sun J, Fiala M, Azab F, Muz B, Sahin I, Vij R, DiPersio JF, Azab AK
    Sci Rep 2021 Sep 29;11(1):19343
  • Machine Learning-Based Scoring Models to Predict Hematopoietic Stem Cell Mobilization in Allogeneic Donors
    Xiang J, Shi M, Fiala MA, Gao F, Rettig MP, Uy GL, Schroeder MA, Weilbaecher KN, Stockerl-Goldstein K, Mollah S, DiPersio JF
    Blood Adv 2021 Sep 23; [Epub ahead of print]
  • Bortezomib in First-Line Therapy Is Associated With Falls in Older Adults With Multiple Myeloma
    Schoenbeck KL, Fiala MA, Wildes TM
    J Geriatr Oncol 2021 Sep;12(7):1005-1009
  • Autologous Stem Cell Transplant for Patients With Multiple Myeloma Between Ages 75 and 78
    Fiala MA, King J, Feinberg D, Goldsmith SR, Schroeder MA, Ghobadi A, Stockerl-Goldstein KE, Vij R, Wildes TM
    Bone Marrow Transplant 2021 Aug;56(8):2016-2018
  • Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
    Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, Flora DB, Griffiths EA, Gulati AP, Hwang C, Koshkin VS, Papadopoulos EB, Robilotti EV, Su CT, Wulff-Burchfield EM, Xie Z, Yu PP, Mishra S, Senefeld JW, Shah DP, Warner JL
    COVID-19 and Cancer Consortium (Contributors include: Fiala MA)

    JAMA Oncol 2021 Jun 17; [Epub ahead of print]
  • Co-Evolution of Tumor and Immune Cells During Progression of Multiple Myeloma
    Liu R, Gao Q, Foltz SM, Fowles JS, Yao L, Wang JT, Cao S, Sun H, Wendl MC, Sethuraman S, Weerasinghe A, Rettig MP, Storrs EP, Yoon CJ, Wyczalkowski MA, McMichael JF, Kohnen DR, King J, Goldsmith SR, O'Neal J, Fulton RS, Fronick CC, Ley TJ, Jayasinghe RG, Fiala MA, Oh ST, DiPersio JF, Vij R, Ding L
    Nat Commun 2021 May 7;12(1):2559
  • A Deficit-Accumulation Frailty Index Predicts Survival Outcomes in Patients With Gynecologic Malignancy
    Mullen MM, McKinnish TR, Fiala MA, Zamorano AS, Kuroki LM, Fuh KC, Hagemann AR, McCourt CK, Mutch DG, Powell MA, Wildes TM, Thaker PH
    Gynecol Oncol 2021 Jun;161(3):700-704
  • Renal Failure Among Multiple Myeloma Patients Utilizing Carfilzomib and Associated Factors in the "Real World"
    Mian HS, Fiala MA, Sanchez L, Vij R, Wildes TM
    Ann Hematol 2021 May;100(5):1261-1266
  • Utilization of Radiation Therapy in Multiple Myeloma: Trends and Changes in Practice
    Ailawadhi S, Frank R, Ailawadhi M, Kanji Z, Jani P, Fiala M, Abdulazeez M, Ahmed S, Aggarwal CS, Aulakh S, Hodge D, Roy V, Alegria VR, Paulus A, Chanan-Khan A, Sher T
    Ann Hematol 2021 Mar;100(3):735-741
  • VLA4-Targeted Nanoparticles Hijack Cell Adhesion-Mediated Drug Resistance to Target Refractory Myeloma Cells and Prolong Survival
    Fontana F, Scott MJ, Allen JS, Yang X, Cui G, Pan D, Yanaba N, Fiala MA, O'Neal J, Schmieder-Atteberry AH, Ritchey J, Rettig M, Simons K, Fletcher S, Vij R, DiPersio JF, Lanza GM
    Clin Cancer Res 2021 Apr 1;27(7):1974-1986
  • Burden of Treatment Among Older Adults With Newly Diagnosed Multiple Myeloma
    Mian HS, Fiala MA, Wildes TM
    Clin Lymphoma Myeloma Leuk 2021 Feb;21(2):e152-e159
  • Overall Survival of Patients With Triple-Class Refractory Multiple Myeloma Treated With Selinexor Plus Dexamethasone Vs Standard of Care in MAMMOTH
    Cornell R, Hari P, Tang S, Biran N, Callander N, Chari A, Chhabra S, Fiala MA, Gahvari Z, Gandhi U, Godby K, Gupta R, Jagannath S, Jagosky M, Kang Y, Kansagra A, Kauffman M, Kodali S, Kumar SK, Lakshman A, Liedtke M, Lonial S, Ma X, Malek E, Mansour J, McGehee EF, Neppalli A, Paul B, Richardson P, Scott EC, Shacham S, Shah J, Siegel DS, Umyarova E, Usmani SZ, Varnado W, Vij R, Costa L
    Am J Hematol 2021 Jan;96(1):E5-E8
  • A Systematic Framework to Rapidly Obtain Data on Patients With Cancer and COVID-19: CCC19 Governance, Protocol, and Quality Assurance
    COVID-19 and Cancer Consortium (Contributors include: Fiala MA)
    Cancer Cell 2020 Dec 14;38(6):761-766
  • Statins Reduce Mortality in Multiple Myeloma: A Population-Based US Study
    Afzal A, Fiala MA, Gage BF, Wildes TM, Sanfilippo K
    Clin Lymphoma Myeloma Leuk 2020 Dec;20(12):e937-e943
  • Primary Refractory Multiple Myeloma: A Real-World Experience With 85 Cases
    Jurczyszyn A, Waszczuk-Gajda A, Castillo JJ, Krawczyk K, Stork M, Pour L, Usnarska-Zubkiewicz L, Potoczek S, Hus I, Davila Valls J, Hari P, Chhabra S, Gentile M, Mikala G, Varga G, Chim CS, Fiala M, Vij R, Schutz N, Rodzaj M, Porowska A, Vesole DH, Druzd-Sitek A, Walewski J, Nooka AK
    Leuk Lymphoma 2020 Dec;61(12):2868-2875
  • Geriatric Assessment and Quality of Life Changes in Older Adults With Newly Diagnosed Multiple Myeloma Undergoing Treatment
    Mian H, Pond GR, Tuchman SA, Fiala MA, Wildes TM
    J Geriatr Oncol 2020 Nov;11(8):1279-1284
  • The Characteristics, Treatment Patterns, and Outcomes of Older Adults Aged 80 and Over With Multiple Myeloma
    Fiala MA, Foley NC, Zweegman S, Vij R, Wildes TM
    J Geriatr Oncol 2020 Nov;11(8):1274-1278
  • Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States
    Yu Y, Brown Wade N, Hwang AE, Nooka AK, Fiala MA, Mohrbacher A, Peters ES, Pawlish K, Bock C, Van Den Berg DJ, Rand KA, Stram D, Conti DV, Auclair D, Colditz GA, Mehta J, Haiman CA, Terebelo H, Janakiraman N, Singhal S, Chiu B, Vij R, Bernal-Mizrachi L, Zonder JA, Huff CA, Lonial S, Orlowski RZ, Cozen W, Ailawadhi S
    JCO Oncol Pract 2020 Oct;16(10):e1169-e1180
  • Racial Disparities in the Utilization of Novel Agents for Frontline Treatment of Multiple Myeloma
    Fiala MA, Wildes TM, Vij R
    Clin Lymphoma Myeloma Leuk 2020 Oct;20(10):647-651
  • DCEP and Bendamustine/Prednisone as Salvage Therapy for Quad- and Penta-Refractory Multiple Myeloma
    Goldsmith SR, Fiala MA, Wang B, Schroeder MA, Wildes TM, Ghobadi A, Stockerl-Goldstein K, Vij R
    Ann Hematol 2020 May;99(5):1041-1048
  • Evolution and Structure of Clinically Relevant Gene Fusions in Multiple Myeloma
    Foltz SM, Gao Q, Yoon CJ, Sun H, Yao L, Li Y, Jayasinghe RG, Cao S, King J, Kohnen DR, Fiala MA, Ding L, Vij R
    Nat Commun 2020 May 29;11(1):2666
  • Targeting CD47 as a Novel Immunotherapy for Multiple Myeloma
    Sun J, Muz B, Alhallak K, Markovic M, Gurley S, Wang Z, Guenthner N, Wasden K, Fiala MA, King J, Kohnen D, Salama NN, Vij R, Azab AK
    Cancers (Basel) 2020 Jan 28;12(2)
  • A Meta-Analysis of Genome-Wide Association Studies of Multiple Myeloma Among Men and Women of African Ancestry
    Du Z, Weinhold N, Song GC, Rand KA, Van Den Berg DJ, Hwang AE, Sheng X, Hom V, Ailawadhi S, Nooka AK, Singhal S, Pawlish K, Peters ES, Bock C, Mohrbacher A, Stram A, Berndt SI, Blot WJ, Casey G, Stevens VL, Kittles R, Goodman PJ, Diver WR, Hennis A, Nemesure B, Klein EA, Rybicki BA, Stanford JL, Witte JS, Signorello L, John EM, Bernstein L, Stroup AM, Stephens OW, Zangari M, Van Rhee F, Olshan A, Zheng W, Hu JJ, Ziegler R, Nyante SJ, Ingles SA, Press MF, Carpten JD, Chanock SJ, Mehta J, Colditz GA, Wolf J, Martin TG, Tomasson M, Fiala MA, Terebelo H, Janakiraman N, Kolonel L, Anderson KC, Le Marchand L, Auclair D, Chiu BC, Ziv E, Stram D, Vij R, Bernal-Mizrachi L, Morgan GJ, Zonder JA, Huff CA, Lonial S, Orlowski RZ, Conti DV, Haiman CA, Cozen W
    Blood Adv 2020 Jan 14;4(1):181-190
  • Adherence to Lenalidomide in Older Adults With Newly Diagnosed Multiple Myeloma
    Mian H, Fiala MA, Wildes TM
    Clin Lymphoma Myeloma Leuk 2020 Feb;20(2):98-104e1
  • Ruxolitinib for Steroid-Refractory Acute Graft-Versus-Host Disease
    Toama W, Fiala MA, Pusic I, Westervelt P, DiPersio JF, Schroeder MA
    Transpl Int 2020 Feb;33(2):244-246
  • Measuring Cardiopulmonary Complications of Carfilzomib Treatment and Associated Risk Factors Using the SEER-Medicare Database
    Fakhri B, Fiala MA, Shah N, Vij R, Wildes TM
    Cancer 2020 Feb 15;126(4):808-813
  • Maintenance Therapy Following Salvage Autologous Stem Cell Transplant in Patients With Multiple Myeloma
    Fiala MA, Vosuri V, Goldsmith S, Schroeder MA, Ghobadi A, Wildes TM, Stockerl-Goldstein KE, Vij R
    Bone Marrow Transplant 2020 Jun;55(6):1188-1190
  • A Comparison of Three Different Approaches to Defining Frailty in Older Patients With Multiple Myeloma
    Isaacs A, Fiala MA, Tuchman S, Wildes TM
    J Geriatr Oncol 2020 Mar;11(2):311-315
  • EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms
    Goldsmith SR, Fiala MA, O'Neal J, Souroullas GP, Toama W, Vij R, Schroeder MA
    Clin Lymphoma Myeloma Leuk 2019 Nov;19(11):744-750
  • Inhibition of E-Selectin (GMI-1271) or E-Selectin Together With CXCR4 (GMI-1359) Re-Sensitizes Multiple Myeloma to Therapy
    Muz B, Azab F, Fiala MA, King J, Kohnen D, Fogler WE, Smith T, Magnani JL, Vij R, Azab AK
    Blood Cancer J 2019 Aug 20;9(9):68
  • Predicting Venous Thromboembolism in Multiple Myeloma: Development and Validation of the IMPEDE VTE Score
    Sanfilippo KM, Luo S, Wang TF, Fiala MA, Schoen M, Wildes TM, Mikhael J, Kuderer NM, Calverley DC, Keller JW, Thomas TS, Carson KR, Gage BF
    Am J Hematol 2019 Nov;94(11):1176-1184
  • A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
    Ghobadi A, Fiala MA, Rettig MP, Schroeder MA, Uy GL, Stockerl-Goldstein KE, Westervelt P, Vij R, DiPersio JF
    Clin Lymphoma Myeloma Leuk 2019 Oct;19(10):e588-e593
  • A Mixed-Methods Study of Stem Cell Transplantation Utilization for Newly Diagnosed Multiple Myeloma
    Fiala MA, Vij R, Wildes TM
    Clin Lymphoma Myeloma Leuk 2019 Sep;19(9):e521-e525
  • Cost Differential Associated With Hospice Use Among Older Patients With Multiple Myeloma
    Fiala MA, Gettinger T, Wallace CL, Vij R, Wildes TM
    J Geriatr Oncol 2020 Jan;11(1):88-92
  • A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
    Schroeder MA, Fiala MA, Huselton E, Cardone MH, Jaeger S, Jean SR, Shea K, Ghobadi A, Wildes TM, Stockerl-Goldstein KE, Vij R
    Clin Cancer Res 2019 Jul 1;25(13):3776-3783
  • African American Patients May or May Not Have Poorer Response Rates After Monoclonal Antibody Treatment: Overreliance on P Values in Underpowered Studies
    Fiala MA
    Cancer 2019 Jul 1;125(13):2321-2322
  • Outcomes of Patients With Multiple Myeloma Refractory to CD38-Targeted Monoclonal Antibody Therapy
    Gandhi UH, Cornell RF, Lakshman A, Gahvari ZJ, McGehee E, Jagosky MH, Gupta R, Varnado W, Fiala MA, Chhabra S, Malek E, Mansour J, Paul B, Barnstead A, Kodali S, Neppalli A, Liedtke M, Narayana S, Godby KN, Kang Y, Kansagra A, Umyarova E, Scott EC, Hari P, Vij R, Usmani SZ, Callander NS, Kumar SK, Costa LJ
    Leukemia 2019 Sep;33(9):2266-2275
  • Next Generation Sequencing-Based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study
    Goldsmith SR, Fiala MA, Dukeman J, Ghobadi A, Stockerl-Goldstein KE, Schroeder MA, Tomasson M, Wildes TM, Vij R
    Clin Lymphoma Myeloma Leuk 2019 May;19(5):285-289
  • Challenges Associated With Living Remotely From a Pediatric Cancer Center: A Qualitative Study
    Walling EB, Fiala M, Connolly A, Drevenak A, Gehlert S
    J Oncol Pract 2019 Mar;15(3):e219-e229
  • PYK2/FAK Inhibitors Reverse Hypoxia-Induced Drug Resistance in Multiple Myeloma
    Muz B, Buggio M, Azab F, de la Puente P, Fiala MA, Padval MV, Weaver DT, Pachter JA, Vij R, Azab AK
    Haematologica 2019 Jul;104(7):e310-e313
  • Development of a Medicare Health Outcomes Survey Deficit-Accumulation Frailty Index and Its Application to Older Patients With Newly Diagnosed Multiple Myeloma
    Mian HS, Wildes TM, Fiala MA
    JCO Clin Cancer Inform 2018;2
  • Secondary Plasma Cell Leukemia: A Multicenter Retrospective Study of 101 Patients
    Jurczyszyn A, Castillo JJ, Avivi I, Czepiel J, Davila J, Vij R, Fiala MA, Gozzetti A, Grzasko N, Milunovic V, Hus I, Madry K, Waszczuk-Gajda A, Usnarska-Zubkiewicz L, Debski J, Atilla E, Beksac M, Mele G, Sawicki W, Jayabalan D, Charlinski G, Gyula Szabo A, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Crusoe E, Hungria V, Richardson P, Laubach J, Guerrero-Garcia T, Liu J, Vesole DH
    Leuk Lymphoma 2019 Jan;60(1):118-123
  • Multiple Myeloma in Patients Up to 30 Years of Age: A Multicenter Retrospective Study of 52 Cases
    Jurczyszyn A, Davila J, Kortum KM, Jayabalan DS, Vij R, Fiala M, Milunovic V, Chim CS, Wisniewska-Piaty K, Waszczuk-Gajda A, Crusoe E, Hajek R, Robak P, Razny M, Zawirska D, Bittrich M, Nahi H, Liu J, Castillo JJ, Vesole DH
    Leuk Lymphoma 2019 Feb;60(2):471-476
  • Multiple Myeloma Patients Ineligible for Randomized Controlled Trials Have Poorer Outcomes Irrespective of Treatment
    Malecek MK, Fiala M, Schroeder M, Dukeman J, Ghobadi A, Stockerl-Goldstein K, Wildes T, Vij R
    Clin Lymphoma Myeloma Leuk 2018 Sep;18(9):e363-e364
  • The Efficacy of Salvage Autologous Stem Cell Transplant Among Patients With Multiple Myeloma Who Received Maintenance Therapy Post Initial Transplant
    Manjappa S, Fiala MA, King J, Kohnen DA, Vij R
    Bone Marrow Transplant 2018 Nov;53(11):1483-1486
  • A Multiple Myeloma-Specific Capture Sequencing Platform Discovers Novel Translocations and Frequent, Risk-Associated Point Mutations in IGLL5
    White BS, Lanc I, O'Neal J, Gupta H, Fulton RS, Schmidt H, Fronick C, Belter EA Jr, Fiala M, King J, Ahmann GJ, DeRome M, Mardis ER, Vij R, DiPersio JF, Levy J, Auclair D, Tomasson MH
    Blood Cancer J 2018 Mar 21;8(3):35
  • Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies
    Fakhri B, Fiala MA, Tuchman SA, Wildes TM
    Clin Lymphoma Myeloma Leuk 2018 Mar;18(3):219-224
  • Cellular Stressors Contribute to the Expansion of Hematopoietic Clones of Varying Leukemic Potential
    Wong TN, Miller CA, Jotte MRM, Bagegni N, Baty JD, Schmidt AP, Cashen AF, Duncavage EJ, Helton NM, Fiala M, Fulton RS, Heath SE, Janke M, Luber K, Westervelt P, Vij R, DiPersio JF, Welch JS, Graubert TA, Walter MJ, Ley TJ, Link DC
    Nat Commun 2018 Jan 31;9(1):455
  • Prognostic Indicators in Primary Plasma Cell Leukaemia: A Multicentre Retrospective Study of 117 Patients
    Jurczyszyn A, Radocha J, Davila J, Fiala MA, Gozzetti A, Grzasko N, Robak P, Hus I, Waszczuk-Gajda A, Guzicka-Kazimierczak R, Atilla E, Mele G, Sawicki W, Jayabalan DS, Charlinski G, Szabo AG, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Avivi I, Rodzaj M, Leleu X, Richez V, Knopinska-Posluszny W, Masternak A, Yee AJ, Barchnicka A, Druzd-Sitek A, Guerrero-Garcia T, Liu J, Vesole DH, Castillo JJ
    Br J Haematol 2018 Mar;180(6):831-839
  • Falls in Older Adults With Multiple Myeloma
    Wildes TM, Fiala MA
    Eur J Haematol 2018 Mar;100(3):273-278
  • Results of a Prospective Randomized, Open-Label, Noninferiority Study of Tbo-Filgrastim (Granix) Versus Filgrastim (Neupogen) in Combination With Plerixafor for Autologous Stem Cell Mobilization in Patients With Multiple Myeloma and Non-Hodgkin Lymphoma
    Bhamidipati PK, Fiala MA, Grossman BJ, DiPersio JF, Stockerl-Goldstein K, Gao F, Uy GL, Westervelt P, Schroeder MA, Cashen AF, Abboud CN, Vij R
    Biol Blood Marrow Transplant 2017 Dec;23(12):2065-2069
  • Similar Survival Outcomes in Patients With Biclonal Versus Monoclonal Myeloma: A Multi-Institutional Matched Case-Control Study
    Jurczyszyn A, Gozzetti A, Gdula-Argasinska J, Czepiel J, Vij R, Fiala M, Valls DJ, Madry K, Waszczuk-Gajda A, Grosicki S, Barchnicka A, Crusoe E, Hungria V, Gentile M, Mele G, Ksieniewicz M, Vesole DH, Castillo JJ
    Ann Hematol 2017 Oct;96(10):1693-1698
  • Tariquidar Sensitizes Multiple Myeloma Cells to Proteasome Inhibitors Via Reduction of Hypoxia-Induced P-Gp-Mediated Drug Resistance
    Muz B, Kusdono HD, Azab F, de la Puente P, Federico C, Fiala M, Vij R, Salama NN, Azab AK
    Leuk Lymphoma 2017 Dec;58(12):2916-2925
  • IgM Myeloma: A Multicenter Retrospective Study of 134 Patients
    Castillo JJ, Jurczyszyn A, Brozova L, Crusoe E, Czepiel J, Davila J, Dispenzieri A, Eveillard M, Fiala MA, Ghobrial IM, Gozzetti A, Gustine JN, Hajek R, Hungria V, Jarkovsky J, Jayabalan D, Laubach JP, Lewicka B, Maisnar V, Manasanch EE, Moreau P, Morgan EA, Nahi H, Niesvizky R, Paba-Prada C, Pika T, Pour L, Reagan JL, Richardson PG, Shah J, Spicka I, Vij R, Waszczuk-Gajda A, Gertz MA
    Am J Hematol 2017 Aug;92(8):746-751
  • Fresh or Cryopreserved CD34(+)-Selected Mobilized Peripheral Blood Stem and Progenitor Cells for the Treatment of Poor Graft Function After Allogeneic Hematopoietic Cell Transplantation
    Ghobadi A, Fiala MA, Ramsingh G, Gao F, Abboud CN, Stockerl-Goldstein K, Uy GL, Grossman BJ, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2017 Jul;23(7):1072-1077
  • Donor-Derived Smoldering Multiple Myeloma Following a Hematopoietic Cell Transplantation for AML
    Fakhri B, Fiala M, Slade M, Westervelt P, Ghobadi A
    Case Rep Hematol 2017;2017:3728429
  • Mobilization of Allogeneic Peripheral Blood Stem Cell Donors With Intravenous Plerixafor Mobilizes a Unique Graft
    Schroeder MA, Rettig MP, Lopez S, Christ S, Fiala M, Eades W, Mir FA, Shao J, McFarland K, Trinkaus K, Shannon W, Deych E, Yu J, Vij R, Stockerl-Goldstein K, Cashen AF, Uy GL, Abboud CN, Westervelt P, DiPersio JF
    Blood 2017 May 11;129(19):2680-2692
  • Racial Disparities in Treatment Use for Multiple Myeloma
    Fiala MA, Wildes TM
    Cancer 2017 May 1;123(9):1590-1596
  • Development of an Algorithm to Distinguish Smoldering Versus Symptomatic Multiple Myeloma in Claims-Based Data Sets
    Fiala MA, Dukeman J, Tuchman SA, Keller M, Vij R, Wildes TM
    JCO Clin Cancer Inform 2017;1
  • The Impact of Diabetes Mellitus and Other Comorbidities on Hematopoietic Stem Cell Collection and Hematologic Recovery Post-Transplantation
    Fiala MA, Slade M, Wang S, Park S, DiPersio J, Stockerl-Goldstein K
    Leuk Lymphoma 2017 Jan;58(1):241-243
  • Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
    Ghobadi A, Choi J, Fiala MA, Fletcher T, Liu J, Eissenberg LG, Abboud C, Cashen A, Vij R, Schroeder MA, Pusic I, Stockerl-Goldstein K, Jacoby M, Uy G, DiPersio J, Westervelt P
    Leuk Res 2016 Oct;49:1-6
  • Racial Disparities in the Outcomes of Patients With Stage IV Pancreatic Adenocarcinoma Are Mediated by Chemotherapy Utilization
    Atkins JJ, Fiala MA, Wang-Gillam A, Wildes TM
    Pancreas 2016 Aug;45(7):e33-4
  • Remobilization of Hematopoietic Stem Cells in Healthy Donors for Allogeneic Transplantation
    Fiala MA, Park S, Slade M, DiPersio JF, Stockerl-Goldstein KE
    Transfusion 2016 Sep;56(9):2331-5
  • A Study of High-Dose Lenalidomide Induction and Low-Dose Lenalidomide Maintenance Therapy for Patients With Hypomethylating Agent Refractory Myelodysplastic Syndrome
    Cherian MA, Tibes R, Gao F, Fletcher T, Fiala M, Uy GL, Westervelt P, Jacoby MA, Cashen AF, Stockerl-Goldstein K, DiPersio JF, Vij R
    Leuk Lymphoma 2016 Nov;57(11):2535-40
  • Central Nervous System Involvement by Multiple Myeloma: A Multi-Institutional Retrospective Study of 172 Patients in Daily Clinical Practice
    Jurczyszyn A, Grzasko N, Gozzetti A, Czepiel J, Cerase A, Hungria V, Crusoe E, Silva Dias AL, Vij R, Fiala MA, Caers J, Rasche L, Nooka AK, Lonial S, Vesole DH, Philip S, Gangatharan S, Druzd-Sitek A, Walewski J, Corso A, Cocito F, Vekemans MC, Atilla E, Beksac M, Leleu X, Davila J, Badros A, Aneja E, Abildgaard N, Kastritis E, Fantl D, Schutz N, Pika T, Butrym A, Olszewska-Szopa M, Usnarska-Zubkiewicz L, Usmani SZ, Nahi H, Chim CS, Shustik C, Madry K, Lentzsch S, Swiderska A, Helbig G, Guzicka-Kazimierczak R, Lendvai N, Waage A, Andersen KT, Murakami H, Zweegman S, Castillo JJ
    Am J Hematol 2016 Jun;91(6):575-80
  • A Phase I Study of Carfilzomib for Relapsed or Refractory Acute Myeloid and Acute Lymphoblastic Leukemia
    Wartman LD, Fiala MA, Fletcher T, Hawkins ER, Cashen A, DiPersio JF, Jacoby MA, Stockerl-Goldstein KE, Pusic I, Uy GL, Westervelt P, Vij R
    Leuk Lymphoma 2016;57(3):728-30
  • A Phase I Study of Thymoglobulin for Relapsed or Refractory Multiple Myeloma
    Keller J, Fiala MA, Dipersio J, Stockerl-Goldstein K, Vij R, Heldermon CD
    Leuk Lymphoma 2016 Feb;57(2):453-455
  • Two Cases of Donor-Derived Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation
    Fiala M, Hutchagowder V, Westervelt P, Stockerl-Goldstein KE, Kulkarni S, Ghobadi A
    Ann Hematol Oncol 2015;2(7):1051
  • Bendamustine, Lenalidomide, and Dexamethasone (BRD) Is Highly Effective With Durable Responses in Relapsed Multiple Myeloma
    Kumar SK, Krishnan A, LaPlant B, Laumann K, Roy V, Zimmerman T, Gertz MA, Buadi FK, Stockerl Goldstein K, Birgin A, Fiala M, Duarte L, Maharaj M, Levy J, Vij R
    Am J Hematol 2015 Dec;90(12):1106-10
  • Maintenance Therapy With Decitabine After Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia and Myelodysplastic Syndrome
    Pusic I, Choi J, Fiala MA, Gao F, Holt M, Cashen AF, Vij R, Abboud CN, Stockerl-Goldstein KE, Jacoby MA, Uy GL, Westervelt P, DiPersio JF
    Biol Blood Marrow Transplant 2015 Oct;21(10):1761-9
  • High-Dose Therapy and Autologous Stem Cell Transplant in Older Adults With Multiple Myeloma
    Wildes TM, Finney JD, Fiala M, Gao F, Vij R, Stockerl-Goldstein K, Carson KR, Mikhael J, Colditz G
    Bone Marrow Transplant 2015 Aug;50(8):1075-82
  • Diabetes Limits Stem Cell Mobilization Following G-CSF but Not Plerixafor
    Fadini GP, Fiala M, Cappellari R, Danna M, Park S, Poncina N, Menegazzo L, Albiero M, DiPersio J, Stockerl-Goldstein K, Avogaro A
    Diabetes 2015 Aug;64(8):2969-77
  • Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma
    Fiala MA, Finney JD, Stockerl-Goldstein KE, Tomasson MH, DiPersio JF, Vij R, Wildes TM
    Biol Blood Marrow Transplant 2015 Jul;21(7):1153-4
  • Socioeconomic Status Is Independently Associated With Overall Survival in Patients With Multiple Myeloma
    Fiala MA, Finney JD, Liu J, Stockerl-Goldstein KE, Tomasson MH, Vij R, Wildes TM
    Leuk Lymphoma 2015;56(9):2643-9
  • Personalization of Cancer Treatment Using Predictive Simulation
    Doudican NA, Kumar A, Singh NK, Nair PR, Lala DA, Basu K, Talawdekar AA, Sultana Z, Tiwari KK, Tyagi A, Abbasi T, Vali S, Vij R, Fiala M, King J, Perle M, Mazumder A
    J Transl Med 2015 Feb 1;13:43
  • A Phase II Study of V-BEAM as Conditioning Regimen Before Second Auto-SCT for Multiple Myeloma
    Wang TF, Fiala MA, Cashen AF, Uy GL, Abboud CN, Fletcher T, Wu N, Westervelt P, DiPersio JF, Stockerl-Goldstein KE, Vij R
    Bone Marrow Transplant 2014 Nov;49(11):1366-70
  • Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients
    Vij R, Mazumder A, Klinger M, O'Dea D, Paasch J, Martin T, Weng L, Park J, Fiala M, Faham M, Wolf J
    Clin Lymphoma Myeloma Leuk 2014 Apr;14(2):131-139e1
  • Phase I Study of Cladribine, Cytarabine, Granulocyte Colony Stimulating Factor (CLAG Regimen) and Midostaurin and All-Trans Retinoic Acid in Relapsed/Refractory AML
    Ramsingh G, Westervelt P, McBride A, Stockerl-Goldstein K, Vij R, Fiala M, Uy G, Cashen A, Dipersio JF, Abboud CN
    Int J Hematol 2014 Mar;99(3):272-8
  • PI3KCA Plays a Major Role in Multiple Myeloma and Its Inhibition With BYL719 Decreases Proliferation, Synergizes With Other Therapies and Overcomes Stroma-Induced Resistance
    Azab F, Vali S, Abraham J, Potter N, Muz B, de la Puente P, Fiala M, Paasch J, Sultana Z, Tyagi A, Abbasi T, Vij R, Azab AK
    Br J Haematol 2014 Apr;165(1):89-101
  • The Characteristics and Outcomes of Patients With Multiple Myeloma Dual Refractory or Intolerant to Bortezomib and Lenalidomide in the Era of Carfilzomib and Pomalidomide
    Wang TF, Ahluwalia R, Fiala MA, Trinkaus KM, Cox DP, Jaenicke M, Moliske CC, Carson KR, Wildes TM, Tomasson MH, Stockerl-Goldstein KE, Vij R
    Leuk Lymphoma 2014 Feb;55(2):337-41